T 2677/16 (Drug target/QIAGEN) of 01.08.2019
- European Case Law Identifier
- ECLI:EP:BA:2019:T267716.20190801
- Date of decision
- 1 August 2019
- Case number
- T 2677/16
- Petition for review of
- -
- Application number
- 03706023.3
- IPC class
- G06F 19/00
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- DRUG DISCOVERY METHODS
- Applicant name
- QIAGEN Redwood City, Inc.
- Opponent name
- -
- Board
- 3.5.05
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 52(2)(a)European Patent Convention Art 52(2)(c)European Patent Convention Art 56
- Keywords
- Modelling disease-related pathways - technical character (no)
Drug target discovery - technical purpose (no)
Inventive step - (no) - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is dismissed.